Voglivo 0.3 Tablet
Marketer
Rhophic Health Care
Salt Composition
Voglibose (0.3mg)
Overview Voglivo 0.3 Tablet
DiaVolve 0.3mg tablets are indicated for the management of type 2 diabetes. This medication assists in regulating postprandial hyperglycemia (high blood sugar after meals), particularly when dietary modifications and other comparable therapies prove insufficient. DiaVolve 0.3mg should be administered immediately prior to each meal. Dosage and frequency are determined individually by your physician to optimize blood glucose control. Discontinuation should only occur under medical supervision; abrupt cessation may elevate blood sugar, potentially causing severe complications such as renal impairment or vision loss. Treatment requires a comprehensive approach, incorporating a balanced diet, regular exercise, and weight management as directed by your doctor. Consistent blood glucose monitoring is essential. Commonly reported adverse effects include bloating, abdominal discomfort, anorexia, constipation, and diarrhea. Report any persistent or bothersome side effects to your physician. While DiaVolve 0.3mg itself does not induce hypoglycemia, concurrent use with other antidiabetic agents (especially insulin or sulfonylureas) may increase this risk. Hypoglycemic episodes necessitate treatment with plain glucose; sucrose is ineffective in this context. Prior to initiating therapy, inform your doctor of any hepatic or renal dysfunction. Contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis, Crohn's disease). Pregnant or lactating women require physician consultation. Always disclose all current medications to ensure treatment safety. Limit alcohol consumption during treatment to minimize the hypoglycemia risk.
Uses of Voglivo 0.3 Tablet
Managing type 2 diabetes
Major Benefits of Voglivo 0.3 Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Voglivo 0.3 Tablet on an empty stomach.
Common Side effects of Voglivo 0.3 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglivo 0.3 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglivo 0.3 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Voglivo 0.3 Tablet works:
0.3 Tablet Voglivo is an antidiabetic drug that works by blocking the activity of intestinal enzymes which digest complex carbohydrates into simple sugars like glucose. This action helps prevent postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglivo 0.3 Tablet with alcohol is not advisable due to safety concerns.
PregnancySAFE IF PRESCRIBED
The use of Voglivo 0.3 Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent harmful effects on fetal development; nonetheless, data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Using 0.3mg of Voglivo during breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by taking a 0.3mg Voglivo tablet.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Voglivo 0.3 Tablet. A modified dosage of Voglivo 0.3 Tablet might be necessary. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Voglivo 0.3 Tablet to patients exhibiting severe hepatic impairment. Dosage modification for Voglivo 0.3 Tablet may be necessary. Physician consultation is recommended.
What if you forget to take Voglivo 0.3 Tablet :
Omit any missed Voglivo 0.3 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Voglivo 0.3 Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
| Actions | Alpha-glucosidase inhibitors |




